These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21535369)

  • 21. Adverse drug reactions in hospitalized children in Fortaleza, Brazil.
    dos Santos DB; Coelho HL
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):635-40. PubMed ID: 16287200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender-based differences in drug prescription: relation to adverse drug reactions.
    Zopf Y; Rabe C; Neubert A; Janson C; Brune K; Hahn EG; Dormann H
    Pharmacology; 2009; 84(6):333-9. PubMed ID: 19844133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of antimicrobial-related adverse drug reactions in hospitalized patients.
    Sun HY; Chen YC; Wang YW; Gau CS; Chang SC
    J Microbiol Immunol Infect; 2008 Apr; 41(2):151-9. PubMed ID: 18473103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse drug reactions of antidepressants and antipsychotics: experience, knowledge and attitudes among Norwegian psychiatrists.
    Castberg I; Reimers A; Sandvik P; Aamo TO; Spigset O
    Nord J Psychiatry; 2006; 60(3):227-33. PubMed ID: 16720514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triazolam use in a university medical center.
    Schwinghammer TL; Young BG; Hirsh JD
    Am J Hosp Pharm; 1992 Dec; 49(12):2939-43. PubMed ID: 1481797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse drug event reporting in intensive care units: a survey of current practices.
    Kane-Gill SL; Devlin JW
    Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug reactions detected by stimulated spontaneous reporting in an internal medicine department in Romania.
    Farcas A; Sinpetrean A; Mogosan C; Palage M; Vostinaru O; Bojita M; Dumitrascu D
    Eur J Intern Med; 2010 Oct; 21(5):453-7. PubMed ID: 20816604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse drug reactions among inpatients in a north Indian referral hospital.
    Uppal R; Jhaj R; Malhotra S
    Natl Med J India; 2000; 13(1):16-8. PubMed ID: 10743370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospital pharmacy compliance with JCAHO standards and ASHP guidelines for reporting adverse drug reactions.
    Tyler LS; Nickman NA
    Am J Hosp Pharm; 1992 Apr; 49(4):845-50. PubMed ID: 1595720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study of adverse drug reactions in a dermatology department.
    Ganeva M; Gancheva T; Lazarova R; Tzvetanova Y; Hristakieva E
    Methods Find Exp Clin Pharmacol; 2007 Mar; 29(2):107-12. PubMed ID: 17440627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of adverse drug reactions using drug and drug target interactions and graph-based methods.
    Lin SF; Xiao KT; Huang YT; Chiu CC; Soo VW
    Artif Intell Med; 2010; 48(2-3):161-6. PubMed ID: 19962282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse drug reactions: a review of relevant factors.
    Ajayi FO; Sun H; Perry J
    J Clin Pharmacol; 2000 Oct; 40(10):1093-101. PubMed ID: 11028248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center)].
    Ciorciaro C; Hartmann K; Kuhn M
    Schweiz Med Wochenschr; 1998 Feb; 128(7):254-8. PubMed ID: 9540150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Food and Drug Administration monitoring of adverse drug reactions.
    Sills JM; Tanner LA; Milstien JB
    Am J Hosp Pharm; 1986 Nov; 43(11):2764-70. PubMed ID: 3799612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender-based differences in the toxicity of pharmaceuticals--the Food and Drug Administration's perspective.
    Miller MA
    Int J Toxicol; 2001; 20(3):149-52. PubMed ID: 11488556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple drug exposure as a risk factor for the seriousness of adverse drug reactions.
    Macedo AF; Alves C; Craveiro N; Marques FB
    J Nurs Manag; 2011 Apr; 19(3):395-9. PubMed ID: 21507111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Food and Drug Administration Office of Women's Health: impact of science on regulatory policy.
    Obias-Manno D; Scott PE; Kaczmarczyk J; Miller M; Pinnow E; Lee-Bishop L; Jones-London M; Chapman K; Kallgren D; Uhl K
    J Womens Health (Larchmt); 2007; 16(6):807-17. PubMed ID: 17678451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse Effects of Common Drugs: General Concepts.
    Karpa KD; Lewis PR; Felix TM
    FP Essent; 2015 Sep; 436():11-6. PubMed ID: 26375993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do standard doses of frequently prescribed drugs cause preventable adverse effects in women?
    Cohen JS
    J Am Med Womens Assoc (1972); 2002; 57(2):105-10, 114. PubMed ID: 11991418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.